» Articles » PMID: 33491565

Aldosterone Sensitivity: an Opportunity to Explore the Pathogenesis of Hypertension

Overview
Specialties Nephrology
Physiology
Date 2021 Jan 25
PMID 33491565
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aldosterone sensitivity is defined as an outcome variable for a given circulating level of aldosterone. In basic and translational studies, aldosterone sensitivity has been measured in differential tissue responses, e.g., lower urine sodium and higher urine potassium, as an index of the renal response; in clinical studies, aldosterone sensitivity has been measured in differential blood pressure responses. The concept of aldosterone sensitivity disrupts the conventional wisdom of the renin-angiotensin-aldosterone system and has the potential to uncover novel mechanisms of hypertension. Here, we review basic and translational science studies that uncovered differential renal responses to aldosterone and connect this earlier work to more recent observational studies and randomized trials that have demonstrated differential blood pressure responses for a given level of aldosterone in healthy and hypertensive persons. Black race and older age are associated with higher aldosterone sensitivity and blood pressure. We also discuss gaps in the field and how future basic and clinical studies might inform mechanisms of differential sensitivity.

Citing Articles

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review.

Miyasako K, Maeoka Y, Masaki T Biomedicines. 2025; 13(1).

PMID: 39857638 PMC: 11760469. DOI: 10.3390/biomedicines13010053.


Evaluation of aldosterone to direct renin ratio, low renin and related Phenotypes in Afro-Colombian patients with apparent treatment resistant hypertension.

Duran C, Bustamante M, Barbosa M, Useche E, Trivino J, Sandoval L Sci Rep. 2024; 14(1):18091.

PMID: 39103362 PMC: 11300880. DOI: 10.1038/s41598-024-67261-w.


Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population.

Shah S, Libianto R, Gwini S, Rusell G, Young M, Fuller P J Endocr Soc. 2024; 8(8):bvae113.

PMID: 38957654 PMC: 11215789. DOI: 10.1210/jendso/bvae113.


Reassessing the management of hypertension: Time to prevent aldosterone-mediated heart failure.

Pitt B, Brown J, Vaidya A, Diez J Eur J Heart Fail. 2024; 26(2):195-198.

PMID: 38239030 PMC: 11418401. DOI: 10.1002/ejhf.3141.


Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis.

Shah S, Zhang J, Gwini S, Young M, Fuller P, Yang J J Hum Hypertens. 2024; 38(5):383-392.

PMID: 38200100 PMC: 11076210. DOI: 10.1038/s41371-023-00891-1.